New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
10:49 EDTEGRXEagle Pharmaceuticals price target raised to $30 from $22 at Cantor
Cantor said Ryanodex, which Eagle Pharmaceuticals has priced significantly above the firm's initial expectations, is planned to launch at the end of this month and should help offset some of the losses associated with argatroban. The firm raised its price target on Eagle to $30 from $22 and reiterates its Buy rating on the shares.
News For EGRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
06:55 EDTEGRXEagle Pharmaceuticals submits NDA for ready-to-use bivalirudin to FDA
Subscribe for More Information
May 19, 2015
08:35 EDTEGRXEagle Pharmaceuticals issued patent for bendamustine rapid infusion product
Subscribe for More Information
May 12, 2015
06:52 EDTEGRXEagle Pharmaceuticals reports Q1 EPS $1.31, consensus $1.47
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use